Valeant Surrenders Early Gains After SILIQ's FDA Approval
February 16, 2017 at 13:17 PM EST
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares are trading lower by $0.42 (2.6 percent) at $16.44 in Thursday's session. Before ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.